Sequana Medical AG Raises CHF 23 Million in a Series C Financing Led by LSP, and Adds an Independent Board Chairman ...

Sequana Medical AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23 million ($26.2 million) in a Series C preferred share financing round led by LSP (Life Science Partners), and co-led by NeoMed Management, VI Partners, BioMedInvest, Entrepreneurs Fund and Capricorn Venture Partners. NeoMed retains its role as the ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1rvXIn5

via IFTTT